Literature DB >> 12188911

Examining the relationship between cancer invasion/metastasis and drug resistance.

Y Liang1, S McDonnell, Martin Clynes.   

Abstract

Studies of cancer invasion/metastasis and drug resistance have in the past generally proceeded along the separate pathways of research. Recently, however, interest has been focused on the possible relationship between drug resistance and cancer invasion and metastasis. A relationship between these two phenotypes has been demonstrated by two types of observation: firstly, some tumor cells selected for resistance to drugs are more invasive/metastatic relative to non-resistant parental cells; secondly, in some cases, secondary (more metastatic) tumors are more resistant to chemotherapeutic drugs than their primary counterparts. In other instances reported in the literature, no correlation is seen between drug exposure/resistance and cancer invasion/metastasis. The possibility that treatment with some chemotherapeutic drugs may be able to promote cancer invasion and metastasis needs further investigation because of its potential clinical relevance. A better understanding of any relationship between drug resistance and cancer invasion could lead to more effective cancer treatment.

Entities:  

Mesh:

Year:  2002        PMID: 12188911     DOI: 10.2174/1568009023333872

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  21 in total

1.  The miR-106b~25 cluster promotes bypass of doxorubicin-induced senescence and increase in motility and invasion by targeting the E-cadherin transcriptional activator EP300.

Authors:  Y Zhou; Y Hu; M Yang; P Jat; K Li; Y Lombardo; D Xiong; R C Coombes; S Raguz; E Yagüe
Journal:  Cell Death Differ       Date:  2013-11-22       Impact factor: 15.828

2.  BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation.

Authors:  Britta Stordal; Kirsten Timms; Angela Farrelly; Danielle Gallagher; Steven Busschots; Mickaël Renaud; Julien Thery; Deborah Williams; Jennifer Potter; Thanh Tran; Greg Korpanty; Mattia Cremona; Mark Carey; Jie Li; Yang Li; Ozlem Aslan; John J O'Leary; Gordon B Mills; Bryan T Hennessy
Journal:  Mol Oncol       Date:  2013-01-31       Impact factor: 6.603

3.  CaNdt80 is involved in drug resistance in Candida albicans by regulating CDR1.

Authors:  Chia-Geun Chen; Yun-Liang Yang; Hsin-I Shih; Chia-Li Su; Hsiu-Jung Lo
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

4.  Investigation of HMN-176 anticancer activity in human tumor specimens in vitro and the effects of HMN-176 on differential gene expression.

Authors:  Leticia Medina-Gundrum; Cesario Cerna; Lionel Gomez; Elzbieta Izbicka
Journal:  Invest New Drugs       Date:  2005-01       Impact factor: 3.850

5.  Elevated expression of E-cadherin in primary breast cancer and its corresponding metastatic lymph node.

Authors:  Lin Chen; Wei Jian; Leisheng Lu; Lijun Zheng; Zhen Yu; Donglei Zhou
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 6.  MiRNAs-mediated cisplatin resistance in breast cancer.

Authors:  Xiu Chen; Peng Lu; Ying Wu; Dan-Dan Wang; Siying Zhou; Su-Jin Yang; Hong-Yu Shen; Xiao-Hui Zhang; Jian-Hua Zhao; Jin-Hai Tang
Journal:  Tumour Biol       Date:  2016-07-22

7.  Tissue transgluaminase 2 expression in meningiomas.

Authors:  Liya Yuan; Amir Behdad; Matthew Siegel; Chaitan Khosla; Ryuji Higashikubo; Keith M Rich
Journal:  J Neurooncol       Date:  2008-06-28       Impact factor: 4.130

8.  Acquired resistance to peloruside A and laulimalide is associated with downregulation of vimentin in human ovarian carcinoma cells.

Authors:  Arun Kanakkanthara; Pisana Rawson; Peter T Northcote; John H Miller
Journal:  Pharm Res       Date:  2012-05-15       Impact factor: 4.200

9.  Identification of proteins differentially expressed in adriamycin-resistant (pumc-91/ADM) and parental (pumc-91) human bladder cancer cell lines by proteome analysis.

Authors:  Qian Meng; Ting Lei; Min Zhang; Jin Zhao; Xu-Hong Zhao; Man Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2012-11-27       Impact factor: 4.553

Review 10.  Targeting Twist expression with small molecules.

Authors:  Haixiang Pei; Yunqi Li; Mingyao Liu; Yihua Chen
Journal:  Medchemcomm       Date:  2016-12-02       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.